Associations between 1400 metabolites and subtypes of endometriosis: a two-sample Mendelian randomisation study
- PMID: 40874543
- DOI: 10.1080/01443615.2025.2552402
Associations between 1400 metabolites and subtypes of endometriosis: a two-sample Mendelian randomisation study
Abstract
Background: Endometriosis is a chronic inflammatory disease with a prevalence of approximately 10% in women of childbearing age. Metabolic pathways have been demonstrated by previous studies to be potential avenues for the development of new therapeutic strategies and may be used for early diagnosis of the disease. This study aimed to investigate the potential causal relationships between 1400 metabolites and various endometriosis subtypes using Mendelian randomisation (MR) analysis.
Methods: Data from a genome-wide association study were analysed. MR analysis was performed using the inverse-variance weighted, MR-Egger, and weighted-median methods, accompanied by heterogeneity testing, sensitivity analysis, and pleiotropy analysis. Metabolic-pathway enrichment analysis was conducted on the preliminarily screened differential metabolites, and colocalisation analysis was subsequently performed for exposure-outcome pairs that remained causally associated after multiple-testing correction.
Results: After multiple-testing correction, only the glycerol-to-palmitoylcarnitine (C16) ratio reduced the risk of stage 1-2 endometriosis (PFDR = 0.045; odds ratio [OR], 0.737; 95% confidence interval [CI], 0.638-0.852) and pelvic peritoneal endometriosis (PFDR = 0.039; OR, 0.721; 95% CI, 0.619-0.841). Colocalisation analysis revealed that they did not share causal variant loci at the genetic level. No reverse causal associations were found in the reverse Mendelian analysis. Metabolic pathway enrichment analysis identified major metabolic pathways, including caffeine metabolism, glutathione metabolism, arginine biosynthesis, sphingolipid metabolism, pantothenate and CoA biosynthesis, plasmalogen synthesis, and biosynthesis of unsaturated fatty acids.
Conclusions: Our study suggests potential causal relationships between metabolites and various endometriosis subtypes from an MR perspective. However, the limited number of associations that survived multiple-testing correction indicates that these findings are preliminary and require validation in larger cohorts. This exploratory analysis may contribute to advancing future research on metabolomics-based diagnosis, treatment, and prevention of endometriosis.
Keywords: Mendelian randomisation; Metabolites; endometriosis; glycerol to palmitoylcarnitine (C16) ratio.
Plain language summary
Endometriosis is a condition in which tissues similar to the uterine lining grow outside the uterus. It affects approximately 1 in 10 reproductive-age women and can cause pain and fertility problems. In this study, we investigated whether certain natural substances in the blood, called metabolites, play a role in different forms of endometriosis. We used genetic data to test over 1,000 metabolites and found that only the glycerol-to-palmitoylcarnitine ratio showed a meaningful link. A higher ratio may reduce the risk of mild or pelvic peritoneal endometriosis. This early finding points to a new direction for future research; nevertheless, more studies are required to confirm this and understand how this metabolite balance may be involved in the disease.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Plasma metabolites associated with endometriosis in adolescents and young adults.Hum Reprod. 2025 May 1;40(5):843-854. doi: 10.1093/humrep/deaf040. Hum Reprod. 2025. PMID: 40107296
-
Exploring the causal association between serum metabolites and erectile dysfunction: a bidirectional Mendelian randomisation study.Int J Impot Res. 2025 Aug;37(8):601-611. doi: 10.1038/s41443-024-00926-2. Epub 2024 Jun 10. Int J Impot Res. 2025. PMID: 38858529
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical